SLC5A2 and bacterial urinary tract infection: One of the classes of drugs with the best-documented effect on the development of UTI are gliflozins (inhibitors of kidney sodium-glucose co-transporters SGLT2), which directly results from their mechanism of inhibiting the reabsorption of glucose from the urine.